Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 482.90 billion as of June 27, 2025. Its market cap has increased by 43.31% in one year.

Market Cap

482.90B

Enterprise Value

490.57B

Revenue

134.35B

Ranking

n/a

PE Ratio

46.12

Stock Price

1,711.20

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 482.90B, an increase of 41,916.94%. That is a compound annual growth rate of 28.53%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	488.77B	7.64%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,006.41B
Divi's Laboratories	1,756.34B
Cipla	1,222.71B
Apollo Hospitals Enterprise	1,021.09B
Zydus Lifesciences	988.07B
Mankind Pharma	950.72B
Aurobindo Pharma	652.36B
Fortis Healthcare	596.95B

Market Cap Rankings